The Centers for Disease Control (CDC) is to purchase 5 million doses of an experimental COVID-19 vaccine by Medigen Vaccine Biologics Corp (高端疫苗), the Hsinchu-based firm said in a regulatory filing yesterday.
The procurement agreement also includes a subsequent purchase of up to 5 million more doses, Medigen said.
The company did not disclose further details, citing terms agreed with the CDC.
Photo: CNA
The delivery of the drug, pending approval, would have a positive effect on the firm’s finances and operations, it said.
Medigen, which is running a phase 2 clinical trial of the vaccine with 3,752 participants, told the Taipei Times earlier this month that it has started large-scale antigen production for the drug.
The company said it would in the middle of next month submit an interim report on the trial to health authorities and hopes that it will gain emergency use authorization for the drug as soon as possible, it has said.
Medigen on May 11 said that it had given a third dose of the vaccine to 45 participants of the trial to test the immunogenicity and safety of a potential booster shot.
Primary data on the trial would be generated early next quarter, it said, adding that these would also be used to study the drug’s efficacy to prevent infections with new COVID-19 variants and for future vaccine development.
Additional reporting by Kao Shih-ching
Intel Corp chief executive officer Lip-Bu Tan (陳立武) is expected to meet with Taiwanese suppliers next month in conjunction with the opening of the Computex Taipei trade show, supply chain sources said on Monday. The visit, the first for Tan to Taiwan since assuming his new post last month, would be aimed at enhancing Intel’s ties with suppliers in Taiwan as he attempts to help turn around the struggling US chipmaker, the sources said. Tan is to hold a banquet to celebrate Intel’s 40-year presence in Taiwan before Computex opens on May 20 and invite dozens of Taiwanese suppliers to exchange views
Application-specific integrated circuit designer Faraday Technology Corp (智原) yesterday said that although revenue this quarter would decline 30 percent from last quarter, it retained its full-year forecast of revenue growth of 100 percent. The company attributed the quarterly drop to a slowdown in customers’ production of chips using Faraday’s advanced packaging technology. The company is still confident about its revenue growth this year, given its strong “design-win” — or the projects it won to help customers design their chips, Faraday president Steve Wang (王國雍) told an online earnings conference. “The design-win this year is better than we expected. We believe we will win
Chizuko Kimura has become the first female sushi chef in the world to win a Michelin star, fulfilling a promise she made to her dying husband to continue his legacy. The 54-year-old Japanese chef regained the Michelin star her late husband, Shunei Kimura, won three years ago for their Sushi Shunei restaurant in Paris. For Shunei Kimura, the star was a dream come true. However, the joy was short-lived. He died from cancer just three months later in June 2022. He was 65. The following year, the restaurant in the heart of Montmartre lost its star rating. Chizuko Kimura insisted that the new star is still down
While China’s leaders use their economic and political might to fight US President Donald Trump’s trade war “to the end,” its army of social media soldiers are embarking on a more humorous campaign online. Trump’s tariff blitz has seen Washington and Beijing impose eye-watering duties on imports from the other, fanning a standoff between the economic superpowers that has sparked global recession fears and sent markets into a tailspin. Trump says his policy is a response to years of being “ripped off” by other countries and aims to bring manufacturing to the US, forcing companies to employ US workers. However, China’s online warriors
RSS